Featured White Papers
Morning Alert for NeoPharm, Inc.
M2 Presswire, March, 2007
 | Content provided in partnership with |  |
M2 PRESSWIRE-29 March 2007-Biotech News: Morning Alert for NeoPharm, Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:29032007 Betcha can't guess what NeoPharm does! The company utilizes two technology platforms -- tumor targeting and liposome drug delivery -- to develop its new cancer drugs.
Its lead drug candidate attacks brain tumors; the treatment is in late-phase clinical trials and has received orphan drug status for malignant glioma. Its liposomal drug delivery candidates target colorectal, breast, lung, ovarian, and other cancers. Another prospective drug is designed to ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Business
- Academy of Marketing Science Review
- Accounting Historians Journal, The
- Accounting History
- AgExporter
- Agricultural Research
- Agricultural and Resource Economics Review
- Air Force Comptroller
- Air Safety Week
- Airline Industry Information
- American Demographics
- American Journal of Potato Research
- Architectural Review, The
- Asian Economic News
- Entrepreneur